Evidence map›Paper›PMID 29046803›Full record

ArticleMolecular and clinical oncology2017

Antitumor activity of yulangsan polysacchrides in mice bearing S180 sarcoma tumors.

Wen'E Cai, Xiaoyu Chen, Qingdong Pan, Shijun Zhang, Luojiao Tan, Xuyong Sun, Renbin Huang, Aijun Xia

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular and clinical oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Wen'E CaiDepartment of Clinical Pharmacy, 303 Hospital of PLA, Nanning, Guangxi 530021, P.R. China.
Xiaoyu ChenDepartment of Pharmacology, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
Qingdong PanDepartment of Clinical Pharmacy, 303 Hospital of PLA, Nanning, Guangxi 530021, P.R. China.
Shijun ZhangDepartment of Pharmacology, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
Luojiao TanDepartment of Diagnosis, Administration of Old Officer of Beiji Temple, Beijing 100191, P.R. China.
Xuyong SunGuangxi Key Laboratory for Transplantation Medicine, Institute of Transplantation Medicine, 303 Hospital of PLA, Nanning, Guangxi 530021, P.R. China.
Renbin HuangDepartment of Pharmacology, Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
Aijun XiaDepartment of Clinical Pharmacy, 303 Hospital of PLA, Nanning, Guangxi 530021, P.R. China.
303 Hospital of People's Liberation Army · CNGuangxi Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sarcoma is one of the most prevalent pediatric tumors and the therapeutic role of chemotherapy has yet to be elucidated. It has been reported that extracts of Longyanshen (Yulangsan) may enhance the sensitivity of drug-resistant cancer cell lines, and improve the immune dysfunction induced by cyclophosphamide (CTX) in mice. The present

Indexed as

antitumorapoptosisimmunitysarcomayulangsan polysaccharide

Identifiers

PMID29046803
PMCPMC5639289
OpenAlexW2749078581

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.